4-Methyl-5-phenyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I

Yuping Zhu; Steven H Olson; Anne Hermanowski-Vosatka; Steven Mundt; Kashmira Shah; Marty Springer; Rolf Thieringer; Samuel Wright; Jianying Xiao; Hratch Zokian; James M Balkovec

doi:10.1016/j.bmcl.2008.04.013

4-Methyl-5-phenyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3405-11. doi: 10.1016/j.bmcl.2008.04.013. Epub 2008 Apr 10.

Authors

Yuping Zhu¹, Steven H Olson, Anne Hermanowski-Vosatka, Steven Mundt, Kashmira Shah, Marty Springer, Rolf Thieringer, Samuel Wright, Jianying Xiao, Hratch Zokian, James M Balkovec

Affiliation

¹ Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. yuping_zhu@merck.com

PMID: 18440811
DOI: 10.1016/j.bmcl.2008.04.013

Abstract

4-Methyl-5-phenyl-(1,2,4)-triazoles were identified as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1). They were active in vitro and in an in vivo mouse pharmacodynamic (PD) model. The synthesis and structure activity relationships are presented.

MeSH terms

11-beta-Hydroxysteroid Dehydrogenase Type 1 / antagonists & inhibitors*
Animals
Combinatorial Chemistry Techniques
Disease Models, Animal
Enzyme Inhibitors / chemical synthesis*
Enzyme Inhibitors / pharmacokinetics
Enzyme Inhibitors / pharmacology
Humans
Mice
Models, Molecular
Molecular Structure
Structure-Activity Relationship
Triazoles / chemical synthesis*
Triazoles / pharmacokinetics
Triazoles / pharmacology*

Substances

Enzyme Inhibitors
Triazoles
11-beta-Hydroxysteroid Dehydrogenase Type 1